This narrative review (Augustine, Kalva, Kim H.A., Zhang, Kim I.; Molecules, 15 Aug 2019) consolidates pH-responsive polypeptide nanocarrier design with 216 references and declares no conflicts of interest . The authors organize carriers by amino acid chemistryβcationic (PLL, pHis, pArg, pTyr, pPro, pTrp) and anionic (pAsp, pGlu)βthen map release by organ (GI tract), tissue (tumor), and cellular (endosomal) pH, a taxonomy that genuinely aids navigation of a scattered field.
The cited targeted cRGD-decorated polyion complex micelle exemplifies the field's promise: ~95% encapsulation, 97 nm DLS size, and acid-triggered DOX release (51% at pH 7.4 β 96% at pH 5.5) with no observed organ toxicity in nude mice (n=6/group) . A companion pGlu/PNIPAM graft-copolymer study shows dual pH/thermo crosslinked micelles (~70 nm) tunable by pH and temperature .
As the authors themselves concede, drug loading and release remain suboptimal, NCA monomer synthesis is moisture-sensitive, and scale-up/biosafety is unresolved . Notably, no pH-responsive polypeptide nanocarrier from this literature pool appears in the registered clinical-trial snapshot provided (NCT03037281, NCT00102596, NCT05289869, NCT05211843, NCT03693612, NCT06889779, NCT02666976, NCT00036738)βall unrelated indicationsβsupporting the review's own translational-gap conclusion. Published in vivo efficacy rests mostly on single xenograft models with n=6 groups , so confidence in clinical extrapolation is low. Counterpoint: the review's breadth (216 refs) partially compensates for its non-systematic method, but citation bias toward positive results is acknowledged and unverifiable here.
A competent, well-structured orienting review of high topical value in 2019; the pH-gate mechanism it describes (e.g., histidine imidazole protonation, hydrazone cleavage) is mechanistically sound, but the field's reproducibility and standardization remain its weak links .
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.